Unrelated reduced intensity conditioning with Treosulfan for allogeneic stem cell transplantation in patients with hematological malignancies.
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Treosulfan (Primary)
- Indications Haematological malignancies
- Focus Therapeutic Use
- Acronyms MiniMUD
- 03 Dec 2005 New trial record.